2012
DOI: 10.1111/ijcp.12066
|View full text |Cite
|
Sign up to set email alerts
|

The challenge of cardiovascular diseases in HIV-positive patients: it’s time for redrawing the maps of cardiovascular risk?

Abstract: Linked Comment: http://dx.doi.org/10.1111/j.1742-1241.2012.02953.x.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
3

Year Published

2013
2013
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 17 publications
0
12
0
3
Order By: Relevance
“…[14][15][16] In fact, if traditional risk factors (smoking status, blood pressure, age, gender, race, and menopausal status) justify much of the cardiovascular risk, additional factors appear to contribute to the increase in cardiovascular risk observed in HIV-infected individuals, including chronic immune activation, accelerated aging, viral factors, and the adverse effects of ART. 17 Significant associations between inflammation and CVD pathogenesis are well established based on large-scale clinical studies. For example, in the Women's Interagency HIV Study (WIHS), greater T cell activation was associated with subclinical arterial disease.…”
Section: Impact Of Non-aids-related Illness On the Life Expectancy Ofmentioning
confidence: 99%
See 1 more Smart Citation
“…[14][15][16] In fact, if traditional risk factors (smoking status, blood pressure, age, gender, race, and menopausal status) justify much of the cardiovascular risk, additional factors appear to contribute to the increase in cardiovascular risk observed in HIV-infected individuals, including chronic immune activation, accelerated aging, viral factors, and the adverse effects of ART. 17 Significant associations between inflammation and CVD pathogenesis are well established based on large-scale clinical studies. For example, in the Women's Interagency HIV Study (WIHS), greater T cell activation was associated with subclinical arterial disease.…”
Section: Impact Of Non-aids-related Illness On the Life Expectancy Ofmentioning
confidence: 99%
“…It was therefore concluded that increasing sets of data support the hypothesis of a relationship between HIV infection and coronary atherosclerosis independent of traditional cardiovascular risk factors, suggesting that persistent inflammation, incomplete immune reconstitution, and residual viral replication might all contribute to increased CAD in HIV-infected individuals. 17,[22][23][24][25] The link between inflammation, virus replication, and ART can also be identified in the setting of HIV-associated metabolic diseases, in which active virus replication can cause proatherogenic elevations in serum lipids, an increase in systemic inflammation, hypercoagulation, and reduced endovascular reactivity. 13,26 In addition, HIV-infected individuals receiving ART may experience various metabolic complications (i.e., impaired glucose metabolism, dyslipidemia, and abnormal body fat distribution), thus potentially increasing their risk of cardiovascular disease.…”
Section: Impact Of Non-aids-related Illness On the Life Expectancy Ofmentioning
confidence: 99%
“…Imaginase que isso ocorra pela possibilidade de alguns ARVs atingirem regiões catalíticas do HIV e, paralelamente, proteínas reguladoras do metabolismo dos lipídios. [7][8][9] Estudos prévios demonstraram que pacientes em tratamento com HAART exibiriam escores mais elevados de risco de acordo com a escala de Framingham. 10 Algumas pesquisas associaram esse fato a uma maior prevalência de pressão arterial elevada e ao hábito de fumar entre os pacientes.…”
Section: Benefícios Sobre Indicadores Cardiovascularesunclassified
“…Embora a European AIDS Clinical Society (EACS), em suas recomendações, sugira a utilização da equação DAD (Data Collection on Adverse Events of Anti-HIV Drugs) 14 para avaliar esse tipo de risco, o método ainda está sendo testado. 7 No método desenvolvido pelo DAD Study Group, além dos marcadores epidemiológicos habitualmente utilizados, incluíram-se dados específicos da doença, como o tempo de infecção, tratamento e princípio ativo dos ARVs utilizados, caracterizando maior especificidade para populações com HIV/AIDS. 15 Outra estratégia é a observação direta do comportamento de variáveis sabidamente relacionadas ao risco de doença cardiovascular.…”
Section: Benefícios Sobre Indicadores Cardiovascularesunclassified
See 1 more Smart Citation